Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver

During development inhibitor of DNA-bind-2 (Id2) regulates proliferation and differentiation. Id2 expression has been detected in cancer cells, yet its cellular function and validity as a therapeutic target remains largely unknown. Immunohistochemical analysis of colorectal cancer (CRC) specimens re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2008-12, Vol.27 (57), p.7192-7200
Hauptverfasser: Gray, M J, Dallas, N A, Van Buren, G, Xia, L, Yang, A D, Somcio, R J, Gaur, P, Mangala, L S, Vivas-Mejia, P E, Fan, F, Sanguino, A M, Gallick, G E, Lopez-Berestein, G, Sood, A K, Ellis, L M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:During development inhibitor of DNA-bind-2 (Id2) regulates proliferation and differentiation. Id2 expression has been detected in cancer cells, yet its cellular function and validity as a therapeutic target remains largely unknown. Immunohistochemical analysis of colorectal cancer (CRC) specimens revealed that Id2 was undetectable in normal colonic mucosa, but occurs in 40% of primary tumors and in most CRC liver metastases ( P
ISSN:0950-9232
1476-5594
DOI:10.1038/onc.2008.356